Skip to main content
Clinical Trials/NL-OMON52104
NL-OMON52104
Recruiting
Not Applicable

High Power Short Duration Radiofrequency Ablation of Atrial Fibrillation using the QDOT MICRO* Catheter - Q-POWER

Vrije Universiteit Medisch Centrum0 sites40 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Vrije Universiteit Medisch Centrum
Enrollment
40
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • All patients \> 18 years of age with atrial fibrillation, eligible for index
  • pulmonary vein isolation according to current ESC guidelines

Exclusion Criteria

  • Unwilling or unable to give written informed consent
  • Prior left atrial ablation
  • Other left atrial arrhythmias including atrial flutters
  • Prior left atrial surgery
  • Severe mitral valve regurgitation
  • Contraindication for gadolinium\-based contrast agents
  • Contraindications for CMR (including metallic implants, cochlear implants,
  • cardiac devices, neurostimulation systems, claustrophobia)
  • Renal insufficiency (eGFR \< 30 ml/min)

Outcomes

Primary Outcomes

Not specified

Similar Trials